Spire Healthcare Group (LSE:SPI) EBIT: £122 Mil (TTM As of Dec. 2025)


LSE:SPI Spire Healthcare Group PLC LSE:SPI
73 GF Score
Price £2.22
GF Value £2.71
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Spire Healthcare Group EBIT?

Spire Healthcare Group LSE:SPI +2.78% 73 EBIT is £122 Mil as of Dec. 2025. GuruFocus rates LSE:SPI with a GF Score™ of 73/100 and a GF Value™ of £2.71 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Spire Healthcare Group's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was £60 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was £122 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Spire Healthcare Group's annualized ROC % for the quarter that ended in Dec. 2025 was 3.77%. Spire Healthcare Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 7.09%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Spire Healthcare Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.62%.

Spire Healthcare Group  (LSE:SPI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Spire Healthcare Group's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=88.2 * ( 1 - 0% )/( (2326.4 + 2353.4)/ 2 )
=88.2/2339.9
=3.77 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2364.5 - 168.3 - ( 20.8 - max(0, 362.4 - 232.2+20.8))
=2326.4

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2377.1 - 149 - ( 34.7 - max(0, 346.8 - 221.5+34.7))
=2353.4

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Spire Healthcare Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=119.4/( ( (1676.3 + max(-78.1, 0)) + (1692.1 + max(-80.2, 0)) )/ 2 )
=119.4/( ( 1676.3 + 1692.1 )/ 2 )
=119.4/1684.2
=7.09 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(95.1 + 46 + 32.8) - (168.3 + 0 + 83.7)
=-78.1

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(77.1 + 46.2 + 32.6) - (149 + 0 + 87.1)
=-80.2

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Spire Healthcare Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=122.1/2171.327
=5.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spire Healthcare Group EBIT Related Terms

Spire Healthcare Group EBIT Historical Data

* Premium members only.

The historical data trend for Spire Healthcare Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spire Healthcare Group EBIT Chart

Spire Healthcare Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.90 89.80 126.10 136.70 122.10

Spire Healthcare Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.80 71.20 65.50 62.40 59.70

LSE:SPI vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Spire Healthcare Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spire Healthcare Group EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Spire Healthcare Group's EV-to-EBIT falls into.


LSE:SPI
73GF Score
Spire Healthcare Group PLC LSE:SPI
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spire Healthcare Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £122 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of £122 Mil mean?
Spire Healthcare Group (LSE:SPI) has a EBIT of £122 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Spire Healthcare Group.
Is Spire Healthcare Group's EBIT too high?
Spire Healthcare Group's current EBIT is £122 Mil. Overall, Spire Healthcare Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's EBIT compare to HCA and THC?
Spire Healthcare Group's EBIT of £122 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Spire Healthcare Group. Spire Healthcare Group's current EBIT is £122 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (LSE:SPI) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.71, compared to a current price of £2.22 — trading 18.1% below its estimated fair value. The current EBIT is £122 Mil. Spire Healthcare Group's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Spire Healthcare Group (LSE:SPI), the current EBIT is £122 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spire Healthcare Group (LSE:SPI) Overvalued in 2026?

Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued. The current stock price of £2.22 is trading 18.1% below its estimated GF Value™ of £2.71. GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.

Key valuation signals for LSE:SPI:

  • EBIT: £122 Mil
  • GF Value™: £2.71 vs. price of £2.22 (18.1% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the LSE:SPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Spire Healthcare Group Business Description

Other Exchanges SPIl:UKS00:Germany
Address 3 Dorset Rise, London, GBR, EC4Y 8EN
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
73GF Score

Get the complete analysis for LSE:SPI

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.22
Price
£2.71
GF Value